Immunome, Inc. logo

Immunome, Inc.

NASDAQ:IMNM

Overview | Financials
Company Name Immunome, Inc.
Symbol IMNM
Currency USD
Price 15.97
Market Cap 959,068,768
Dividend Yield 0%
52-week-range 6.65 - 30.958
Industry Biotechnology
Sector Healthcare
CEO Dr. Clay B. Siegall Ph.D.
Website https://immunome.com

An error occurred while fetching data.

About Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2

Related Stocks

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.71 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

0.157 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

4.11 USD

Nutriband Inc. logo

Nutriband Inc.

NTRB

4.47 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.79 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

9.54 USD

Financials

Numbers are in millions USD

Numbers are in millions USD